研究與發展
為我們的患者工作
我們的研究與發展團隊致力於發現、開發和提供可能改變患者生活的藥物，並在高度未滿足的需求領域建立新的照護標準。我們正在創造改變人生的藥物，用以消除世界上一些最棘手病症：癌症、心臟和免疫系統疾病以及血液疾病。工作內容並不容易，但所做的事獨特又有趣。您將改寫規則、解決最艱難的挑戰，並創造奇蹟。
Explore careers in Research & Development
我們對於自己在腫瘤學、血液學、免疫學、心血管學和神經科學等核心治療領域取得的進展感到自豪。 我們多元化和具前瞻性的研發項目專注於治療領域的研究，我們相信很有機會在該領域為患者提供變革型藥物。在開發改變生命的新一代突破性療法方面，BMS 是您最佳的選擇。您將體驗到有趣的工作、令人振奮的職涯成長，以及在各自領域中處於領導地位的優秀隊友。這可能會改變您的職涯。
Our next neuroscience breakthrough need authors
We are excited to re-enter the field of neuroscience, seeking innovative treatments for patients living with neuropsychiatric disorders such as schizophrenia and neurological conditions like Alzheimer’s disease. You can join us on this exciting journey to transform the lives of patients around the world. It may just transform your career.
Discover the innovation of RayzeBio.
RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes.
RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors.
Leading the way to scientific innovation for patients
Endpoints News Women in Biopharma R&D
OCTOBER 2024
Mariann Micsinai-Balan, VP, GBDS Data Science & Statistical Methodology has been featured for her outstanding contributions to our novel computational methods.
ACS Heroes of Chemistry Award
OCTOBER 2024
Our chemists are honored to be recognized for the ACS Heroes of Chemistry Award for the seventh time in the past ten years.
This year, we celebrate their dedicated work to deliver the first oral treatment for patients living with plaque psoriasis.
我們的職涯故事
聽聽我們世界各地研究與發展團隊成員的故事，瞭解他們每天為患者所做的工作。
Learn the story of how chimeric antigen receptor (CAR) T cell therapy went from hypothesis to groundbreaking treatment. Committed to improving cell therapy science, BMS is advancing a robust pipeline of cell therapies.
English 
Japanese 
French 
German 
Italian 
Korean 
Portuguese 
Chinese (China) 
Spanish 
Chinese (Taiwan) 
